Convalescent (Immune) Plasma Followed by Intravenous Immunoglobulin Infusion in an Adolescent with Severe COVID-19
Coronavirus disease 2019 (COVID-19) pandemic has drawn attention over old immunotherapeutic agents such as convalescent (immune) plasma (CIP). Here, an adolescent with severe COVID-19 case requiring CIP and intravenous immunoglobulin (IVIG) treatments is described. A 17-year-old male patient was bro...
Main Authors: | Öner Özdemir, Bahri Elmas, Hüseyin Sütlüoğlu, Mehmet Cemal Dönmez |
---|---|
Format: | Article |
Language: | English |
Published: |
Duzce University
2021-08-01
|
Series: | Düzce Tıp Fakültesi Dergisi |
Subjects: | |
Online Access: | https://dergipark.org.tr/tr/download/article-file/1772177 |
Similar Items
-
Potential Immunological Treatments in COVID-19 Patients
by: Muhammet Mesut Nezir Engin, et al.
Published: (2021-04-01) -
How Secure was Convalescent Plasma Administration to Non-severe COVID-19 Cases with Lymphopenia?
by: Ahmet Emre Hatır, et al.
Published: (2022-09-01) -
Treatment of a case of COVID-19 by intravenous immunoglobulin
by: Mustafa Çolak, et al.
Published: (2021-03-01) -
Immunoglobulins or convalescent plasma to tackle COVID-19: buying time to save lives – current situation and perspectives
by: Adriana Tamburello, et al.
Published: (2020-04-01) -
Importance of immunoglobulin therapy for COVID-19 patients with lymphocytopenia
by: Heba K. Nabih
Published: (2021-02-01)